Designer drugs to improve mental performance

ISSN： 2195-2175

Source： PHARMAKON, Vol.3, Iss.3, 2015-05, pp. : 218-224

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Designer drugs: the biologic therapies

By Johnston Sarah

Clinical Medicine, Vol. 6, Iss. 4, 2006-07 ,pp. : 337-343

Royal College Of Physicians

Access to resources Recommend Favorite

Metabolism of Designer Drugs of Abuse

Current Drug Metabolism, Vol. 6, Iss. 3, 2005-01 ,pp. : 259-274

Bentham Science Publishers

Access to resources Recommend Favorite

Chemistry and toxicological analysis of new designer drugs

By Paul Liane D.

PHARMAKON, Vol. 1, Iss. 6, 2013-11 ,pp. : 472-481

Govi-Verlag

Access to resources Recommend Favorite

Metabolism of Designer Drugs of Abuse: An Updated Review

Current Drug Metabolism, Vol. 11, Iss. 5, 2010-01 ,pp. : 468-482

Bentham Science Publishers

Access to resources Recommend Favorite

A new trend in drugs-of-abuse; the 2C-series of phenethylamine designer drugs

By de Boer Douwe Bosman Ingrid

Pharmacy World and Science, Vol. 26, Iss. 2, 2004-04 ,pp. : 110-113

Springer Publishing Company

Access to resources Recommend Favorite